Complete Response to Third-Line Treatment with Trifluridine/tipiracil (TAS-102) in Stage IV Colon Adenocarcinoma.
Exploration of targeted anti-tumor therapy（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Exploration of targeted anti-tumor therapy（2023）